Full Name
MEDAER, Rob
Email
rob.medaer@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 45 (Search time: 0.022 seconds).

Issue DateTitleAuthor(s)TypeCat.
12013Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDe Ridder, Dirk; Van der Aa, Frank; Debruyne, Jan; D'hooghe, Marie-Beatrice; Dubois, Benedicte; Guillaume, Daniel; Heerings, Marco; Ilsbroukx, Stefan; MEDAER, Rob ; Nagels, Guy; Seeldrayers, Pierrette; Van Landegem, William; Willekens, Barbara; Zicot, Anne-FrancoiseJournal ContributionA1
22010Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing-remitting Multiple Sclerosis (ASIIMS) trialGonsette, Richard E.; Sindic, Christian; D'hooghe, Marie B.; De Deyn, Peter-Paul; MEDAER, Rob ; Michotte, Alex; Seeldrayers, Pierrette; Guillaume, DanielJournal ContributionA1
32009Some factors contributing to the stabilisation of normal human fingersVAN ZWIETEN, Koos Jaap ; SCHMIDT, Klaus ; BEX, Geert Jan ; LIPPENS, Peter ; DUYVENDAK, Wim ; MEDAER, Rob Proceedings PaperC2
42009The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosisDe Stefano, N.; Filippi, M.; Confavreux, C.; Vermersch, P.; Simu, M.; Sindic, C.; Hupperts, R.; Bajenaru, O.; Edan, G.; Grimaldi, L.; Marginean, I.; MEDAER, Rob ; Orefice, G.; Pascu, I.; Pelletier, J.; Sanders, E.; Scarpini, E.; Mancardi, G. L.Journal ContributionA1
52008Autoantibody profiling in multiple sclerosis: Further characterization of novel antigenic candidatesSOMERS, Veerle ; SOMERS, Klaartje ; GOVARTS, Cindy ; Hupperts, Raymond; MEDAER, Rob ; STINISSEN, Piet Journal ContributionM
62008Association of interferon beta and inosine in relapsing-remitting multiple sclerosis (ASIIMS): a multi-centre, randomized, double-blind, placebo-con trolled phase II (proof of concept) trial in 157 patientsGonsette, Richard E.; Sindic, Christian; D'Hooghe, Marie-Beatrice; MEDAER, Rob ; Michotte, Alex; De Deyn, Peter; Seeldrayers, Pierrette; Guillaume, Daniel; Metz, Rene; de Noordhout, Alain Maertens; Dupuis, Michel; Cras, Patrick; Decoo, Danny; Van Zandijcke, MichelJournal ContributionM
72008Autoantibody profiling in multiple sclerosis reveals novel antigenic candidatesSOMERS, Veerle ; GOVARTS, Cindy ; SOMERS, Klaartje ; Hupperts, R.; MEDAER, Rob ; STINISSEN, Piet Journal ContributionA1
82008Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell levelVENKEN, Koen ; HELLINGS, Niels ; THEWISSEN, Marielle ; SOMERS, Veerle ; HENSEN, Karen; RUMMENS, Jean-Luc ; MEDAER, Rob ; Hupperts, Raymond; STINISSEN, Piet Journal ContributionA1
92007Compromised CD4+CD25Hi regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3 positive cells and a reduced FOXP3 expression at the single-cell levelVENKEN, Koen ; HELLINGS, Niels ; THEWISSEN, Marielle ; SOMERS, Veerle ; Hensen, K.; RUMMENS, Jean-Luc ; MEDAER, Rob ; Hupperts, R.; STINISSEN, Piet Journal ContributionM
102007Autoantibody profiling in multiple sclerosis reveals novel antigenic candidatesSOMERS, Veerle ; GOVARTS, Cindy ; SOMERS, Klaartje ; Hupperts, R; MEDAER, Rob ; STINISSEN, Piet Journal ContributionM
112006T cell vaccination in multiple sclerosis with CSF-derived activated cd4+T cells: results of a placebo-controlled trialSTINISSEN, Piet ; MEDAER, Rob ; HELLINGS, Niels ; VANROOSE, Erwin ; Barkhof, F.; RAUS, Jef Journal ContributionM
122006T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trialSTINISSEN, Piet ; MEDAER, Rob ; HELLINGS, Niels ; Barkhof, F.; RAUS, Jef Journal ContributionM
132006Secondary progressive in contrast to relapsing - Remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T cell function and FOXP3 expressionVENKEN, Koen ; HELLINGS, Niels ; Hensen, K; RUMMENS, Jean-Luc ; MEDAER, Rob ; D'hooghe, MB; Dubois, B; RAUS, Jef ; STINISSEN, Piet Journal ContributionM
142006Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T-Cell function and FOXP3 expressionVENKEN, Koen ; HELLINGS, Niels ; Hensen, K.; RUMMENS, Jean-Luc ; MEDAER, Rob ; D'hooghe, M.; Dubois, W.; RAUS, Jef ; STINISSEN, Piet Journal ContributionA1
152003Long-term effects of T cell vaccination in multiple sclerosisSTINISSEN, Piet ; HERMANS, Guy; HELLINGS, Niels ; MEDAER, Rob ; RAUS, Jef Proceedings PaperC1
162003T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot studyVAN DER AA, Annegret ; HELLINGS, Niels ; MEDAER, Rob ; Gelin, G; PALMERS, Yvan ; RAUS, Jef ; STINISSEN, Piet Journal ContributionA1
172003History of MSMEDAER, Rob Book SectionB3
182002Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis association with clinical and MRI activityHELLINGS, Niels ; Gellin, G.; MEDAER, Rob ; BRUCKERS, Liesbeth ; PALMERS, Yvan ; RAUS, Jef ; STINISSEN, Piet Journal ContributionA1
192002Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?BUNTINX, Mieke ; AMELOOT, Marcel ; STEELS, Paul ; JANSSEN, Paul ; MEDAER, Rob ; GEUSENS, Piet ; RAUS, Jef ; STINISSEN, Piet Journal ContributionA1
202001T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controlsHELLINGS, Niels ; Baree, M.; Verhoeven, C; D'hooghe, MB; MEDAER, Rob ; Bernard, C.C.A.; RAUS, Jef ; STINISSEN, Piet Journal ContributionA1